Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

I.V. Bijnsdorp, F.A.E. Kruyt, M Fukushima, K Smid, S. Gokoel, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)440-447
JournalCancer science
Issue number2
Publication statusPublished - 2010

Cite this